ARKG Holdings of Organovo (ONVO) - Updated Daily
Key Statistics
EarningsSee Full Calendar
| Date | August 05, 2022 | Revenue | Expected$6.55m Actual▫️ | EPS | Expected Actual▫️ |
|---|
Statistics
Institutional Ownership Trends
News That Matters
| Description | |
|---|---|
| Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's proprietary technology is being used to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function and disease. Organovo's advances include cell type-specific compartments, prevalent intercellular tight junctions, and the formation of microvascular structures. Management believes these attributes can enable critical complex, multicellular disease models that can be used to develop clinically effective drugs for selected therapeutic areas. | |
| Website | |
| www.organovo.com |
Research Notes and Commentary for ONVO
No Research Notes Found for ONVO